Cargando…
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
The development of new strategic therapies for multidrug-resistant bacteria, like the use of non-antimicrobial approaches and/or drugs repurposed to be used as monotherapies or in combination with clinically relevant antibiotics, has become urgent. A therapeutic alternative for infections by multidr...
Autores principales: | Miró-Canturri, Andrea, Ayerbe-Algaba, Rafael, del Toro, Raquel, Mejías, Manuel Enrique-Jiménez, Pachón, Jerónimo, Smani, Younes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230278/ https://www.ncbi.nlm.nih.gov/pubmed/34073235 http://dx.doi.org/10.3390/ph14060507 |
Ejemplares similares
-
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2019) -
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2022)